Hans Kristian Moen Vollan
AstraZeneca (Switzerland)(CH)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Cancer-related Molecular Pathways, Cancer Immunotherapy and Biomarkers, Bioinformatics and Genomic Networks
Most-Cited Works
- → Principles and methods of integrative genomic analyses in cancer(2014)382 cited
- → Copynumber: Efficient algorithms for single- and multi-track copy number segmentation(2012)345 cited
- → Recurrent PTPRB and PLCG1 mutations in angiosarcoma(2014)312 cited
- → TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance(2014)308 cited
- → Triple-Negative Breast Cancer and the Need for New Therapeutic Targets(2013)175 cited
- → Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients(2010)153 cited
- → First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study(2023)147 cited
- → Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast Cancer(2013)131 cited
- → Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome(2017)121 cited
- → Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling(2013)119 cited